High-rolling investors have positioned themselves bearish on Cerevel Therapeutics Hldg CERE, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CERE often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 16 options trades for Cerevel Therapeutics Hldg. This is not a typical pattern.
The sentiment among these major traders is split, with 12% bullish and 87% bearish. Among all the options we identified, there was one put, amounting to $199,000, and 15 calls, totaling $853,002.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $35.0 to $42.5 for Cerevel Therapeutics Hldg during the past quarter.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Cerevel Therapeutics Hldg's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Cerevel Therapeutics Hldg's substantial trades, within a strike price spectrum from $35.0 to $42.5 over the preceding 30 days.
Cerevel Therapeutics Hldg 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CERE | PUT | TRADE | BEARISH | 08/16/24 | $0.3 | $0.2 | $0.4 | $40.00 | $199.0K | 8.3K | 5.1K |
| CERE | CALL | SWEEP | BEARISH | 08/16/24 | $2.35 | $2.25 | $2.25 | $42.50 | $87.3K | 8.2K | 1.3K |
| CERE | CALL | SWEEP | BEARISH | 08/16/24 | $2.35 | $2.2 | $2.2 | $42.50 | $85.1K | 8.2K | 1.8K |
| CERE | CALL | SWEEP | BULLISH | 12/20/24 | $2.45 | $2.4 | $2.45 | $42.50 | $83.7K | 743 | 418 |
| CERE | CALL | SWEEP | BEARISH | 12/20/24 | $10.0 | $9.8 | $9.8 | $35.00 | $66.6K | 2.0K | 196 |
About Cerevel Therapeutics Hldg
Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.
Where Is Cerevel Therapeutics Hldg Standing Right Now?
- With a trading volume of 7,024,720, the price of CERE is up by 2.37%, reaching $44.4.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 11 days from now.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cerevel Therapeutics Hldg options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
